Echo for fellows.

🚨 Game changer in cardiac imaging 🚨 Non-invasive #CCTA is no longer the future — it is the new standard for stent evaluation. Photon Counting CT revealing stent strut details and subtle edge hyperplasia PCRonline 🫀 TCTMD Heart_SCCT CoreAalst European Society of Cardiology Journals

Reminder: No benefit in advising caffeine abstention in patients with atrial fibrillation #MedEd

#AI will replace much of what we do, but there are some things that are irreplaceable! Content based on a fun debate between Folkert Asselbergs & me at #ESCCongress. Synthesis led by Tauben Averbuch MD #EHJ European Society of Cardiology Journals academic.oup.com/eurheartj/adva…

Presented at #ENDO2025: In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results:

Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF Dapagliflozin did not significantly alter ApoM overall; however, an inverse association between ApoM and NT-proBNP was observed in dapagliflozin-treated

🚨 Finerenone Approved by US FDA in HF based on #FINEARTSHF Finerenone (Kerendia) is a non-steroidal MRA indicated to reduce the risk of CV death, hospitalization for HF, & urgent HF visits in adult patients with HF with LVEF>= 40% bayer.com/media/en-us/us…

U.S. FDA Approves #Finerenone for New Indication in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥ 40% bayer.com/media/download… Bayer AG

Echo for fellows. Cause of MR?

What's new in heart failure? June 2025 This month's newsletter highlights key updates in heart failure (HF) research, including congestion management, remote pulmonary artery pressure (PAP) monitoring, acute and advanced HF care, cardio-oncology, HF with mildly reduced and

False. But controlling your BP, cholesterol, blood sugar, maintaining healthy weight, exercising, not smoking does cut your CVD risk.

☕ Coffee and cardiovascular disease. Read this State-of-the-Art review published in #EHJ 👉 ow.ly/bAhj50WpJCa EHJ Editor-in-Chief Rocco Montone

Do you agree with pay cuts to highly trained specialists who spend many additional years in training and pay increases to primary care doctors? Why or why not ?

AI beats cardiologists in detecting structural heart disease based on the EKG nature.com/articles/s4158…

Just 5 years ago, HFpEF was described as the “stepchild” of HF with no approved therapies. Today, there are 5 US FDA therapies: ✅ Empagliflozin (#EMPEROR) ✅ Dapagliflozin (#DELIVER) ✅ Sotagliflozin (#SOLOISTWHF) ✅ Sacubitril/Valsartan (#PARAGONHF) ✅ Finerenone (#FINEARTSHF)

1-channel smartwatch ECG, 30 seconds; rhythm?

The Effects of #Inclisiran on the Subclinical Inflammatory Markers of Atherosclerotic Cardiovascular Disease in Patients at High Cardiovascular Risk mdpi.com/1424-8247/18/6…

#PlaqueMatters Ron Blankstein #SCCT2025 quantitative plaque analysis 🌟Fast: be done at scale since Al techniques allow fast throughput 🌟Accurate: Multiple studies comparing to IVUS 🌟Prognostic: data in multiple cohorts 🌟changes patient management DECIDE 🌟$ new reimbursement

How severe is the AR? What echo criteria are we going to use in such cases? Why is the CWD through LVOT showing “bidirectional” AR signal? ⁦Chittur Sivaram⁩ ⁦Ritu Thamman MD⁩

Someone asked me, "What do you miss? " and i said "I miss the way I viewed the world before I knew too much about it."